glp 1 and pet scan Nareg Varjabedian: Emerging Clinical Insight - GLP-1 Agonists May Interfere with FDG PET-CT Imaging Brown Adipose Tissue Mimicking Head

Obesity as a correlate of outcome in patients with bipolar I disorder

[9] [10] If you experience metallic taste or other side effects with Ozempic, you should report this through the Yellow Card scheme (via yellowcard.mhra.gov.uk or the Yellow Card app)

There is substantial evidence confirming that excessive ROS acts as common apoptosis-inducing factors, with mitochondria serving as the primary pro-apoptotic target [35]

Novo Nordisk - Regulatory Approval (December 2025): FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill-which launched in January 2026 [3]

It functions as a signaling molecule that tells your cells to burn fat, take up glucose independent of insulin, and clean up damaged mitochondrial components